Received Dec 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
use of Arexvy in a 32-year-old; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of inappropriate age at vaccine administration in a 32-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. The patient's past medical history included lung transplant. On an unknown date, the patient received the 1st dose of Arexvy (unknown arm). On an unknown date, an unknown time after receiving Arexvy, the patient experienced inappropriate age at vaccine administration (Verbatim: use of Arexvy in a 32-year-old). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 16-DEC-2025 The batch number was not provided, and we are unable to contact the reporter.
Medical History/Concurrent Conditions: Lung transplant